Authors
Latest:
ARVO 2025: 8 year retrospective of DIMS spectacle lens in childrenAt ARVO 2025, in Salt Lake City, Utah, Carly Lam, PhD, MSc, and Tsz Wing Leung, PhD talked about the evaluation of the visual performance of 2 modified DIMS spectacle lens designs.
Latest:
The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucomaWeighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.
Latest:
ARVO 2025: Walk through a novel triaging framework for emergent retinal pathologiesResearchers stratified a dataset of more than 100 patients in an emergency department to see which patients may be indicated for retinal artery occlusions.
Latest:
EyeCon 2024: Myopia interventions across the lifespanAdam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.
Latest:
Ophthalmology sees AI-powered impact on cataract and diabetic eye diseaseShameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.
Latest:
Laser vision correction procedures soar in wake of COVID-19According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.
Latest:
Envision Summit 2025: Understanding hyperglycemia in diabetic retinopathyAt the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.
Latest:
Blog: A call to stop discarding eye medications after a single use or before expiration dateIn a blog, Mackenzie Andrews, the CCO and a co-founder of Nanodropper, discusses the need to update policies on single-use and early disposal of eyedrops.
Latest:
S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal diseaseThe DRD Cure Accelerator, highlighted at the CCOI-Stanford Summit, is a global initiative advancing clinical research and collaborations to eliminate vision loss from diabetic retinal disease.
Latest:
Recent changes to cornea: Preferred Practice PatternsA Q&A with PPP Committee Cornea/External Disease Panel member Daniel S. Choi, MD.
Latest:
Preserving patients’ vision by monitoring glaucoma progression rateThree approaches to examination provide a comprehensive overview
Latest:
Keratoconus management: Lessons learned from an unusual timeTimely access to effective diagnosis and cross-linking is key to positive outcomes
Latest:
New therapeutic targets, drug development for RPSimply slowing disease progression is no longer enough.
Latest:
ARVO 2025: 12-month results in myopic children using combination treatment of atropine and DIMS spectacle lensesAt ARVO 2025, in Salt Lake City, Utah, Noemi Guemes-Villahoz, MD, PhD, talked about 12-month results of vision-related quality of life in myopic children using combination treatment with atropine and DIMS (Defocus Incorporated Multiple Segments) spectacle lenses.
Latest:
Bringing biologics to eye healthOphthalmologists, optometrists gain nonpharmacological treatment options for some of the eye’s most complex issues, providing better outcomes.
Latest:
Throwing everything away ... except the patient and the surgeonSingle-use cataract surgery comes with several safety and quality attributes.
Latest:
AI-related innovations for laser cataract technology mark a milestone in history of deviceThe integration of artificial intelligence in laser cataract technology is shifting the paradigm for the future of cataract surgery and is driving increased precision and improved outcomes for patients.
Latest:
Early outer retinal findings on en face and cross-sectional OCTRhegmatogenous retinal detachment studied.
Latest:
Innovation and the clinician-scientistA discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Latest:
Novel approaches to treating severe ocular surface and corneal damageSevere ocular surface and corneal damage an unseen public health burden.
Latest:
Taking care of your patients’ eyes in a digital worldIt is important for patients to understand what digital eye strain is and its causes.
Latest:
ARVO 2025: Barsha Lal, PhD, presents an atropine study that addresses families' accomodative concernsA one-drop, low dose atropine study assesses accommodative amplitude and dynamics, with clinically applicable findings.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNew acrylic implant provides option for patients with endothelial dysfunction.
Latest:
BLOG: The PTVT Trial and Clinical ApplicationsJoseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.
Latest:
The search for an antifibrotic drug for use with pediatric glaucoma devicesInflammation and scarring are the primary obstacles with pirfenidone.
Latest:
Rethinking dry eye disease with acute steroid treatmentAccording to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation
Latest:
NeuroOp Guru: Neuro-Ophthalmology interprofessional eConsultsAndrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance
